Nestle confirms its full-year targets after its thriving Nespresso coffee business and strong demand in emerging markets keep up sales growth in the third quarter... more
Welcome, Irene Rosenfeld. The secrecy surrounding her visit — the first the Kraft boss has made to the UK since her company bought Cadbury in February — would not have been excessive had she been a head of state rather than a chocolate manufacturer... more
So, as Goldman Sachs bids farewell to one of its biggest rainmakers of the past decade — Simon Dingemans, who is joining GlaxoSmithKline — City Spy wonders how confident the Fleet Street investment bank now feels about winning juicy future contracts with the Lib-Cons... more
GlaxoSmithKline stuns the City with the appointment of one of the Square Mile's most famous mergers and acquisitions 'rainmakers' to be its next chief financial officer.... more
Two lawyers allegedly made nearly £80,000 in unlawful profits after using insider information to buy shares in a small biotech firm on the brink of a corporate buy out... more
Shares in British biotech Antisoma plunge 72% to an all-time low price of 9p after the Chiswick-based company called off a late-stage trial of one of its biggest hopes... more
Market Round-up: Shares in transport group Arriva get another shove as Germany’s national rail operator Deutsche Bahn confirms it made an approach over a possible cash offer... more
Could Novartis be circling drugs group Antisoma? Speculation grew in the City after ING said it believed the cancer-drug developer could prove an attractive target for the Swiss giant... more
Specialist drugmaker Alliance Pharma says strong trading during the last few months of last year helped turnover soar 42% to hit £31 million for the year to December... more
Swiss pharmaceuticals firm Novartis splashes out £23.8 billion to take over Alcon, one of the biggest makers of contact lens solutions and surgical eye parts... more
Father and son who used coded messages about Chinese meals to exchange illegal share tips convicted of insider trading that made them more than £100,000... more
Two partners in the London offices of American law firms and the finance director of a British company taken over in 2006 by drugs giant Novartis have been committed for trial to Southwark Crown Court by City of Westminster magistrates on eight charges of insider dealing ... more
Merchant ships, which have been riding at anchor off our shores for months, are now building-up a full head of steam as they look to benefit from increased Chinese demand for raw materials ... more
British drug giant AstraZeneca was today suffering the ill effects of medical research that criticised Seroquel, a schizophrenia medicine that is the pharma firm's second best-selling product ... more
The UK's medical watchdog has recalled multiple generic drugs from Britain's pharmacy shelves due to "serious" deficiencies, in a move that threatens to damage the reputation of non-branded medicines ... more
A dirty-brown brick building close to Northern Line station Mill Hill East is an unlikely place to find the saviour of the pharmaceuticals industry... more
pharmaceuticals: European drug stocks tumbled after Barack Obama targeted high drug prices in his 2010 budget, underlining the importance of U.S. sales to companies based in Basel, London and Paris... more
Morning:
6°c
